Immunobiology

Editorial
pp. 1-1(1)
Author: Schwaeble W.J.

Preface
pp. 3-3(1)
Authors: Lackner K.J.; von Landenberg P.

Clinical and epidemiological aspects in the antiphospholipid syndrome
pp. 5-11(7)
Authors: Cervera R.; Asherson R.A.

Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?
pp. 13-16(4)
Authors: Sherer Y.; Shoenfeld Y.

Atherogenic autoantigen: oxidized LDL complexes with 2-glycoprotein I
pp. 17-22(6)
Authors: Matsuura E.; Kobayashi K.; Koike T.; Shoenfeld Y.; Khamashta M.A.; Hughes G.R.V.

Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome
pp. 23-28(6)
Authors: Alves J.D.; Ames P.R.J.

Endothelium as a target for antiphospholipid antibodies
pp. 29-36(8)
Authors: Riboldi P.; Gerosa M.; Raschi E.; Testoni C.; Meroni P.L.

Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies
pp. 37-42(6)
Authors: Gharavi A.E.; Pierangeli S.S.; Harris E.N.

Antibodies to factor XII: a possible predictive marker for recurrent foetal loss
pp. 43-46(4)
Authors: Jones D.W.; Gallimore M.J.; Winter M.

Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome
pp. 47-50(4)
Authors: Katzav A.; Kloog Y.; Korczyn A.D.; Molina V.; Blank M.; Shoenfeld Y.; Chapman J.

Nodular regenerative hyperplasia (NRH) of the liver – a manifestation of ‘organ-specific antiphospholipid syndrome'?
pp. 51-57(7)
Authors: Klein R.; Goller S.; Bianchi L.

Frequency and specificities of antiphospholipid antibodies (aPL) in volunteer blood donors
pp. 59-63(5)
Authors: McIntyre J.A.; Wagenknecht D.R.; Waxman D.W.

The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis: A retrospektive study from a single center
pp. 65-71(7)
Authors: Landenberg P.v.; Schölmerich J.; Kempis J.v.; Lackner K.J.

Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal – implications for antiphospholipid syndrome and systemic lupus erythematosus
pp. 73-81(9)
Authors: Gaipl U.S.; Beyer T.D.; Baumann I.; Voll R.E.; Stach C.M.; Heyder P.; Kalden J.R.; Manfredi A.; Herrmann M.